Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
RA Capital Management, L.P. | 5,202,145 9.990% |
1,038,934 (+24.96%) |
Filing History |
| 2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | Astria Therapeutics, Inc. ATXS |
RA Capital Management, L.P. | 5,105,213 9.000% |
692,063 (+15.68%) |
Filing History |
| 2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | NewAmsterdam Pharma Company N.V. NAMS |
RA Capital Management, L.P. | 9,095,589 9.990% |
898,256 (+10.96%) |
Filing History |
| 2024-11-14 5:46 pm Sale |
2024-09-30 | 13G | Ascendis Pharma A/S ASND |
RA Capital Management, L.P. | 9,710,428 16.100% |
-396,972 (-3.93%) |
Filing History |
| 2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | Geron Corporation GERN |
RA Capital Management, L.P. | 63,319,553 9.990% |
8,174,051 (+14.82%) |
Filing History |
| 2024-11-14 5:46 pm Sale |
2024-09-30 | 13G | Praxis Precision Medicines, Inc. PRAX |
RA Capital Management, L.P. | 761,955 4.300% |
-473,644 (-38.33%) |
Filing History |
| 2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | Regulus Therapeutics Inc. RGLS |
RA Capital Management, L.P. | 766,834 1.200% |
766,834 (New Position) |
Filing History |
| 2024-11-14 5:46 pm Unchanged |
2024-09-30 | 13G | Bicycle Therapeutics plc BCYC |
RA Capital Management, L.P. | 2,253,000 4.700% |
0 (Unchanged) |
Filing History |
| 2024-11-14 5:46 pm Unchanged |
2024-09-30 | 13G | Celcuity Inc. CELC |
RA Capital Management, L.P. | 1,286,960 3.400% |
0 (Unchanged) |
Filing History |
| 2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN |
RA Capital Management, L.P. | 6,381,144 6.400% |
1,167,483 (+22.39%) |
Filing History |
| 2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | Taysha Gene Therapies, Inc. TSHA |
RA Capital Management, L.P. | 21,539,465 9.990% |
2,869,376 (+15.37%) |
Filing History |
| 2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | Tenaya Therapeutics, Inc. TNYA |
RA Capital Management, L.P. | 7,980,736 9.990% |
1,032,500 (+14.86%) |
Filing History |
| 2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | RxSight, Inc. RXST |
RA Capital Management, L.P. | 3,916,825 9.900% |
512,540 (+15.06%) |
Filing History |
| 2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | Sera Prognostics, Inc. SERA |
RA Capital Management, L.P. | 3,032,808 9.400% |
985,587 (+48.14%) |
Filing History |
| 2024-11-14 5:46 pm Sale |
2024-09-30 | 13G | Structure Therapeutics Inc. GPCR |
RA Capital Management, L.P. | 5,690,316 3.300% |
-1,534,995 (-21.24%) |
Filing History |
| 2024-11-14 5:46 pm Sale |
2024-09-30 | 13G | Third Harmonic Bio, Inc. THRD |
RA Capital Management, L.P. | 1,280,826 3.100% |
-752,230 (-37.00%) |
Filing History |
| 2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | Tourmaline Bio, Inc. TRML |
RA Capital Management, L.P. | 2,538,925 9.900% |
493,897 (+24.15%) |
Filing History |
| 2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | UroGen Pharma Ltd. URGN |
RA Capital Management, L.P. | 3,206,271 7.100% |
122,713 (+3.98%) |
Filing History |
| 2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | Unicycive Therapeutics, Inc. UNCY |
RA Capital Management, L.P. | 10,472,375 9.990% |
7,000,269 (+201.61%) |
Filing History |
| 2024-11-14 5:46 pm Sale |
2024-09-30 | 13G | Apogee Therapeutics, Inc. APGE |
RA Capital Management, L.P. | 1,961,863 3.400% |
-16,038 (-0.81%) |
Filing History |